Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
71,941,794
-
Number of holders
-
632
-
Total 13F shares, excl. options
-
69,185,010
-
Shares change
-
+448,391
-
Total reported value, excl. options
-
$24,703,501,155
-
Value change
-
+$168,106,325
-
Put/Call ratio
-
1.84%
-
Number of buys
-
317
-
Number of sells
-
-264
-
Price
-
$359.1
Significant Holders of WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) as of Q2 2021
704 filings reported holding WST - WEST PHARMACEUTICAL SERVICES INC - Common Stock as of Q2 2021.
WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) has 632 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 69,185,010 shares
of 71,941,794 outstanding shares and own 96.17% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (8,388,535 shares), BlackRock Inc. (7,604,412 shares), PRICE T ROWE ASSOCIATES INC /MD/ (5,338,372 shares), STATE STREET CORP (3,410,935 shares), FRANKLIN RESOURCES INC (3,374,432 shares), APG Asset Management N.V. (2,531,368 shares), WCM INVESTMENT MANAGEMENT, LLC (1,680,273 shares), GEODE CAPITAL MANAGEMENT, LLC (1,299,088 shares), Neuberger Berman Group LLC (1,273,349 shares), and BAMCO INC /NY/ (1,264,323 shares).
This table shows the top 632 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.